Scientists have successfully engineered the most complicated human cell lines ever indicating that our genomes are more tolerant to significant structural alte ...

Learn more about whether Catalyst Pharmaceuticals, Inc. or CRISPR Therapeutics AG is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Molecular subunits link to produce polymer chains that can connect through their backbones and cross-linked molecules to form ...

According to the National Capital Poison Center, a not-for-profit poison control organization, at least 85 drugs—including ...

Read about exa-cel being rolled out on the NHS, providing a 'functional cure' for some patients with severe sickle cell ...

The most complex engineering of human cell lines ever has been achieved by scientists, revealing that our genomes are more resilient to significant structural changes than was previously thought.

The National Institute for Health and Care Excellence (NICE) has approved Vertex Pharmaceuticals’ Casgevy (exagamglogene ...

ORNL researchers developed a method to upcycle discarded plastics into high-value macromolecules, enhancing properties for ...

Scientists in China have created mice with two biological fathers, a milestone that challenges our understanding of mammalian ...

BizTimes Media’s 24th annual Economic Trends event on Thursday featured insights and predictions from an economist, local business leaders and an academic ...

"Our new express license platform represents an exciting step forward in democratizing access to the foundational CRISPR/Cas9 IP. By simplifying the process and making it more affordable ...